Inhibition of NPC1L1 disrupts adaptive responses of drug-tolerant persister cells to chemotherapy.
Zhang Z, Qin S, Chen Y, Zhou L, Yang M, Tang Y, Zuo J, Zhang J, Mizokami A, Nice EC, Chen HN, Huang C, Wei X.
Zhang Z, et al. Among authors: yang m.
EMBO Mol Med. 2022 Feb 7;14(2):e14903. doi: 10.15252/emmm.202114903. Epub 2022 Jan 13.
EMBO Mol Med. 2022.
PMID: 35023619
Free PMC article.